Kiyotaka Nakano

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe et al. · Cancer Research · 2004 · 297 citations · Full text

Medicine, Molecular Biology, Oncology +17

Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Takahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita et al. · Cancer Research · 2008 · 176 citations

Medicine, Oncology, Pharmacology +12

A long-acting anti–IL-8 antibody improves inflammation and fibrosis in endometriosis

Ayako Nishimoto, Izumi Sato, Kiyotaka Nakano et al. · Science Translational Medicine · 2023 · 105 citations

Veterinary Medicine, Gynecology, Immunology +11

A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor

Tetsuro Orita, Hiroyuki Tsunoda, Naohiro Yabuta et al. · Blood · 2004 · 67 citations · Full text

Medicine, Hematology, Pharmacology +13

Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization

Kiyotaka Nakano, Takahiro Ishiguro, Hiroko Konishi et al. · Anti-Cancer Drugs · 2010 · 64 citations

Pharmacy, Molecular Biology, Oncology +17